Cybercriminals demand $25 million ransom from Novo Nordisk after month‑long breach, highlighting growing ransomware threats to major biotech firmsExecutive summary: Hackers infiltrated Novo Nordisk’s networks over a two‑month period and demanded a $25 million ransom following a cyber‑attack. The breach poses reputational, operational and regulatory risks for one of the world’s largest diabetes device manufacturers and could affect investor confidence in the sector. Novo Nordisk, the unidentified hacker group, Danish cyber‑crime authorities and potentially international law‑enforcement agencies. Authorities will likely launch a formal investigation, Novo Nordisk may issue a public statement on mitigation steps, and the incident could trigger heightened scrutiny of cybersecurity practices across the pharmaceutical industry.According to the Handelsblatt report, hackers infiltrated Novo Nordisk’s internal networks for over two months before demanding a $25 million payment. Danish authorities have been alerted and are working with law‑enforcement to investigate the breach. The incident underscores the increasing vulnerability of large pharmaceutical companies to cyber‑extortion.Connected developmentsNovo Nordisk et Eli Lilly, deux champions en lice pour le faramineux marché des médicaments antiobésitéOpen the full case file on Beyond →
Social Pulse
AI estimate · not scraped